Sona Deshmukh, MBBS, MPH

CRS:

BJMC

Role:

Research Staff

Position:

Study Coordinator

Dr. Deshmukh is Study Coordinator for the Tuberculosis-Diabetes study at the Byramjee Jeejeebhoy Government Medical College-JHU Clinical Research Site, funded by the NIH/National Institute of Allergy and Infectious Diseases (NIAID). Her research interests include the epidemiology of noncommunicable diseases and policy reforms for the same.

The BJGMC Clinical Research Site is a member of a the Baltimore-Washington-India Clinical Trials Unit, a collaborative research partnership among BJGMC, Johns Hopkins School of Medicine, and Whitman Walker Health in Washington, DC, to conduct clinical research for the world’s largest HIV therapeutic trial networks: the AIDS Clinical Trials Group (ACTG) and the International Maternal Pediatric and Adolescent AIDS Clinical Trial Network (IMPAACT).

Dr. Deshmukh has more than five years of experience in public health, programme management, policy design, and community-based research studies for noncommunicable diseases. She has published two research publications. Following a short tenure as Medical Officer in a government hospital, she worked under the dynamic leadership of Dr. Abhay Bang for two years in their esteemed research organization SEARCH, in Gadchiroli, India. Here she designed, implemented, and managed various community-based research projects conducted in 86 villages in Gadchiroli.

Further she took the opportunity to work in the state health department for three years as District Programme Officer to implement and monitor the National Programme for Prevention and Control of Non Communicable Diseases in Chandrapur, Maharashtra. Following her field experience, she briefly served for six months as a senior consultant for public health to government of Maharashtra.

Dr. Deshmukh received a MBBS in medicine from Maharashtra University of Health Sciences in Nashik, India, and a Master of Public Health degree from Tata Institute of Social Sciences (TISS) in Mumbai, India.

Categories

Leadership Committees
CRS
Roles

Clinical Trials

HPTN 069: A Phase II Randomized, Double-Blind, Study of the...

HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...

Read More

A5350: Effects of Visbiome Extra Strength on Gut Microbiome...

Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...

Read More

Identification of Biomarkers That Can Predict Progression...

Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...

Read More

P1070, Dose-Finding and Pharmacogenetic Study of Efavirenz...

Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More